For example, blocking MMP activation or MMP-9 knock-out (KO) prevented degradation of CLN-5 and OCLN, and attenuated BBB disruption, in cerebral ischemia/reperfusion animal models [52,53]. Here, OCLN is linked to Cerebral ischemia.